Specificity: FOXD4L1 Antibody detects endogenous levels of total FOXD4L1.
Host: Rabbit
Application: WB, IF/ICC
Species Reactivity: Human, Mouse
Summary
Specifications
Antibody Isotype
IgG
Species Reactivity
Human; Mouse
Immunogen
A synthesized peptide derived from human FOXD4L1, corresponding to a region within C-terminal amino acids.
Conjugate
Unconjugated
Applications
Application Notes
WB 1:500-1:1000 IF/ICC 1:100-1:500
General Notes
This product (Catalog No. DPABH-21841) is a rabbit-derived polyclonal antibody raised against human FOXD4L1. This antibody exhibits cross-reactivity with FOXD4L1 from mouse. It has been affinity purified by Protein A. This gene is a member of the forkhead/winged-helix (FOX) family of transcription factors with highly conserved FOX DNA-binding domains. Members of the FOX family of transcription factors are regulators of embryogenesis and may play a role in human cancer. This gene lies in a region of chromosome 2 that surrounds the site where two ancestral chromosomes fused to form human chromosome 2. This region is duplicated elsewhere in the human genome, primarily in subtelomeric and pericentromeric locations, thus mutiple copies of this gene have been found. [provided by RefSeq, Jul 2008]. DPABH-21841 is suitable for use in WB 1 (500-1:1000), IF/ICC 1 (100-1:500) applications. DPABH-21841 is supplied as a liquid formulation in Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human FOXD4L1 (C-terminal) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.